Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 03
2018
|
Juan Fernando Posada President - LA SMO |
SELL
Open market or private sale
|
Direct |
4,000
-14.19%
|
$328,000
$82.4 P/Share
|
Aug 03
2018
|
Juan Fernando Posada President - LA SMO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+12.42%
|
$288,000
$72.14 P/Share
|
Aug 02
2018
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,723
-54.16%
|
$787,563
$81.41 P/Share
|
Aug 02
2018
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,723
+35.13%
|
$466,704
$48.17 P/Share
|
Aug 02
2018
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
242
+2.93%
|
-
|
Aug 02
2018
|
Mary Theresa Grabowski Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
377
+16.97%
|
-
|
Aug 02
2018
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Indirect |
25
+0.28%
|
-
|
Aug 02
2018
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
16,515
-23.22%
|
$1,337,715
$81.0 P/Share
|
Aug 02
2018
|
Carolyn M Tastad CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
16,515
+18.84%
|
$792,720
$48.17 P/Share
|
Aug 02
2018
|
Valarie L Sheppard Controller, Treas. & Group VP |
BUY
Grant, award, or other acquisition
|
Direct |
975
+4.15%
|
-
|
Aug 02
2018
|
Juan Fernando Posada President - LA SMO |
SELL
Open market or private sale
|
Direct |
5,600
-9.6%
|
$453,600
$81.2 P/Share
|
Aug 02
2018
|
Juan Fernando Posada President - LA SMO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+14.37%
|
$360,000
$72.14 P/Share
|
Aug 01
2018
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Open market or private sale
|
Direct |
26,946
-27.52%
|
$2,155,680
$80.54 P/Share
|
Aug 01
2018
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,946
+21.37%
|
$1,616,760
$60.15 P/Share
|
Aug 01
2018
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
16,768
-12.44%
|
$1,341,440
$80.31 P/Share
|
Aug 01
2018
|
Carolyn M Tastad CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
11,755
+14.14%
|
$846,360
$72.14 P/Share
|
Aug 01
2018
|
Valarie L Sheppard Controller, Treas. & Group VP |
SELL
Open market or private sale
|
Direct |
27,000
-55.64%
|
$2,160,000
$80.66 P/Share
|
Aug 01
2018
|
Valarie L Sheppard Controller, Treas. & Group VP |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+35.75%
|
$1,296,000
$48.17 P/Share
|
Jul 27
2018
|
Francis S Blake Director |
BUY
Bona fide gift
|
Direct |
37
+0.34%
|
-
|
Jul 02
2018
|
Ciserani Giovanni GrpPres-Global F&HC,Baby&Fem |
SELL
Payment of exercise price or tax liability
|
Direct |
1,067
-1.69%
|
$82,159
$77.91 P/Share
|
Jul 02
2018
|
Carolyn M Tastad CEO - Health Care |
SELL
Payment of exercise price or tax liability
|
Direct |
288
-0.48%
|
$22,176
$77.91 P/Share
|
Jul 02
2018
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Payment of exercise price or tax liability
|
Direct |
677
-1.07%
|
$52,129
$77.91 P/Share
|
Jul 02
2018
|
David S Taylor Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
2,875
-1.7%
|
$221,375
$77.91 P/Share
|
Jun 12
2018
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
405
+1.14%
|
-
|
Jun 12
2018
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
357
+2.68%
|
-
|
Jun 12
2018
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
421
+2.15%
|
-
|
Jun 12
2018
|
Kenneth I Chenault Director |
BUY
Grant, award, or other acquisition
|
Direct |
357
+0.94%
|
-
|
Jun 12
2018
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
454
+0.62%
|
-
|
Jun 12
2018
|
Scott D Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
405
+0.53%
|
-
|
Jun 12
2018
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
357
+3.16%
|
-
|
Jun 11
2018
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
5,300
-4.35%
|
$408,100
$77.41 P/Share
|
Jun 11
2018
|
Ciserani Giovanni GrpPres-Global F&HC,Baby&Fem |
SELL
Open market or private sale
|
Direct |
12,034
-16.02%
|
$926,618
$77.41 P/Share
|
Jun 11
2018
|
Ioannis Skoufalos Global Product Supply Officer |
SELL
Open market or private sale
|
Direct |
4,098
-21.15%
|
$315,546
$77.41 P/Share
|
Jun 04
2018
|
Gary A Coombe CEO - Grooming |
SELL
Open market or private sale
|
Direct |
1,529
-22.61%
|
$113,146
$74.25 P/Share
|
May 09
2018
|
Steven D Bishop CEO - Health Care |
BUY
Bona fide gift
|
Indirect |
410
+16.33%
|
-
|
May 09
2018
|
Steven D Bishop CEO - Health Care |
SELL
Bona fide gift
|
Direct |
410
-0.96%
|
-
|
May 02
2018
|
Steven D Bishop CEO - Health Care |
SELL
Open market or private sale
|
Direct |
2,075
-4.65%
|
$147,325
$71.87 P/Share
|
May 01
2018
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Discretionary transaction
|
Indirect |
14,717
-50.0%
|
$1,044,907
$71.94 P/Share
|
Mar 13
2018
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
345
+1.82%
|
-
|
Mar 13
2018
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
330
+0.95%
|
-
|
Mar 13
2018
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
377
+0.52%
|
-
|
Mar 13
2018
|
Scott D Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
330
+0.44%
|
-
|
Mar 13
2018
|
Kenneth I Chenault Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+0.76%
|
-
|
Mar 13
2018
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+2.62%
|
-
|
Mar 13
2018
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
121
+0.95%
|
-
|
Mar 01
2018
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Open market or private sale
|
Direct |
1,313
-3.68%
|
$102,414
$78.59 P/Share
|
Mar 01
2018
|
Marc S. Pritchard Chief Brand Officer |
SELL
Open market or private sale
|
Direct |
8,502
-8.24%
|
$663,156
$78.59 P/Share
|
Mar 01
2018
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Open market or private sale
|
Direct |
2,353
-3.59%
|
$183,534
$78.59 P/Share
|
Mar 01
2018
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
94
-0.16%
|
$7,332
$78.59 P/Share
|
Mar 01
2018
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
458
-5.07%
|
$35,724
$78.59 P/Share
|